Viridian Therapeutics Stock (VRDN)
Track Viridian Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
VRDN
Viridian Therapeutics
healthcare
$17.41
▲ +3.33 (+23.91%) past year
Market Cap
$1.88B
P/E Ratio
—
1Y Return
+23.91%
EPS (TTM)
-$3.76
Read the latest TheStreet Pro articles mentioning Viridian Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
1 articleDaily Diary Mentions
0 mentionsNo diary mentions for VRDN yet.